Sudarshan Pharma Industries Limited (BOM:543828)
24.91
-0.38 (-1.50%)
At close: Mar 9, 2026
BOM:543828 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,995 | 7,350 | 1,784 | 960 | - | - | Upgrade
|
| Market Cap Growth | -28.87% | 312.09% | 85.79% | - | - | - | Upgrade
|
| Enterprise Value | 8,165 | 8,573 | 2,007 | 1,312 | - | - | Upgrade
|
| Last Close Price | 24.91 | 30.54 | 7.41 | 5.56 | - | - | Upgrade
|
| PE Ratio | 29.86 | 46.07 | 15.57 | 13.64 | - | - | Upgrade
|
| PS Ratio | 0.93 | 1.46 | 0.39 | 0.21 | - | - | Upgrade
|
| PB Ratio | 4.26 | 5.59 | 1.60 | 0.95 | - | - | Upgrade
|
| P/TBV Ratio | 4.46 | 5.76 | 1.67 | 0.96 | - | - | Upgrade
|
| P/FCF Ratio | - | 24.33 | 30.22 | - | - | - | Upgrade
|
| P/OCF Ratio | - | 21.06 | 18.41 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.27 | 1.70 | 0.43 | 0.28 | - | - | Upgrade
|
| EV/EBITDA Ratio | 17.52 | 21.73 | 8.48 | 8.62 | - | - | Upgrade
|
| EV/EBIT Ratio | 17.86 | 22.31 | 8.94 | 9.17 | - | - | Upgrade
|
| EV/FCF Ratio | - | 28.37 | 34.01 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.56 | 1.30 | 0.94 | 0.34 | 1.03 | 1.32 | Upgrade
|
| Debt / EBITDA Ratio | 4.69 | 4.33 | 4.43 | 2.24 | 2.78 | 4.08 | Upgrade
|
| Debt / FCF Ratio | - | 5.65 | 17.76 | - | - | 20.26 | Upgrade
|
| Net Debt / Equity Ratio | 1.54 | 1.28 | 0.92 | 0.22 | 1.02 | 1.26 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.64 | 4.28 | 4.36 | 1.47 | 2.76 | 3.91 | Upgrade
|
| Net Debt / FCF Ratio | - | 5.58 | 17.49 | -0.52 | -5.54 | 19.40 | Upgrade
|
| Asset Turnover | - | 1.47 | 1.80 | 2.49 | 3.02 | 2.46 | Upgrade
|
| Inventory Turnover | - | 3.89 | 5.27 | 7.10 | 9.47 | 8.69 | Upgrade
|
| Quick Ratio | - | 0.63 | 0.82 | 0.79 | 0.72 | 0.87 | Upgrade
|
| Current Ratio | - | 1.29 | 1.48 | 1.68 | 1.26 | 1.23 | Upgrade
|
| Return on Equity (ROE) | - | 13.12% | 10.77% | 10.76% | 20.06% | 12.60% | Upgrade
|
| Return on Assets (ROA) | - | 7.01% | 5.44% | 4.83% | 5.36% | 5.28% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.91% | 11.00% | 9.98% | 11.56% | 13.43% | 11.01% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 26.90% | 18.30% | 12.60% | 29.10% | 23.80% | Upgrade
|
| Earnings Yield | 3.50% | 2.17% | 6.42% | 7.33% | - | - | Upgrade
|
| FCF Yield | - | 4.11% | 3.31% | -44.92% | - | - | Upgrade
|
| Dividend Yield | - | - | - | 0.54% | - | - | Upgrade
|
| Payout Ratio | - | - | 6.30% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -3.91% | -1.30% | 0.83% | -66.88% | 5.63% | - | Upgrade
|
| Total Shareholder Return | -3.91% | -1.30% | 0.83% | -66.34% | 5.63% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.